Tivic Health Systems (NASDAQ:TIVC – Get Free Report) and Schrodinger (NASDAQ:SDGR – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.
Institutional and Insider Ownership
4.3% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 0.5% of Tivic Health Systems shares are owned by insiders. Comparatively, 21.0% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Tivic Health Systems and Schrodinger”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tivic Health Systems | $780,000.00 | 3.43 | -$9.31 million | ($8.62) | -0.29 |
| Schrodinger | $207.54 million | 7.01 | -$187.12 million | ($2.48) | -7.97 |
Tivic Health Systems has higher earnings, but lower revenue than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Tivic Health Systems, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Tivic Health Systems has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.77, indicating that its share price is 77% more volatile than the S&P 500.
Profitability
This table compares Tivic Health Systems and Schrodinger’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tivic Health Systems | -148.49% | -22.69% | -18.94% |
| Schrodinger | -76.22% | -45.70% | -24.81% |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Tivic Health Systems and Schrodinger, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tivic Health Systems | 1 | 0 | 0 | 0 | 1.00 |
| Schrodinger | 1 | 3 | 4 | 0 | 2.38 |
Schrodinger has a consensus target price of $26.29, indicating a potential upside of 32.96%. Given Schrodinger’s stronger consensus rating and higher probable upside, analysts plainly believe Schrodinger is more favorable than Tivic Health Systems.
Summary
Schrodinger beats Tivic Health Systems on 9 of the 14 factors compared between the two stocks.
About Tivic Health Systems
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
About Schrodinger
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.
